All In MedTech

Device Trial Radar · NCT06107361

Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

360

Actual

Start

Nov 7, 2023

Primary completion

Sep 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Corewell Health EastAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 30, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.

Conditions

  • Peripheral Intravenous Vein Catheter Phlebitis
  • Intravenous Infection

Interventions

  • B. Braun 6.35cm 20 gauge ultralong intravenous catheterDevice

    B Braun Medical Inc, 6.35cm 20 gauge ultralong intravenous catheter

  • BD 5.71 cm 20 gauge AccucathDevice

    Bard Access Systems, Inc, BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival of the BBraun 6.35 centimeter 20 gauge ultralong intravenous catheter compared to the BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wireTime frame: up to 15 days or the duration of the IV catheter
  2. Time to insertionTime frame: First day of hospitalization
  3. First-stick success rateTime frame: First day of hospitalization

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beaumont Hospital - Royal Oak

    Royal Oak, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.